|1.||Kenyon, S: 5 articles (10/2008 - 01/2001)|
|2.||Taylor, D J: 5 articles (10/2008 - 03/2001)|
|3.||Perry, Caroline M: 5 articles (01/2004 - 01/2002)|
|4.||Jacobs, Michael R: 4 articles (03/2007 - 10/2002)|
|5.||Wynne, Brian: 4 articles (08/2006 - 10/2002)|
|6.||Soriano, Francisco: 4 articles (08/2006 - 11/2003)|
|7.||Ponte, Carmen: 4 articles (08/2006 - 11/2003)|
|8.||Twynholm, Monique: 3 articles (01/2015 - 11/2003)|
|9.||van der Palen, Job: 3 articles (01/2015 - 04/2011)|
|10.||Hendrix, Ron: 3 articles (01/2015 - 04/2011)|
06/01/1986 - "BRL25000 proved to be very effective in the treatment of PPNG infection and cured all of 121 patients treated. "
02/16/1985 - "It was concluded that clavulanate-potentiated amoxycillin was an effective treatment of skin infections both under experimental and clinical conditions."
02/01/1985 - "From these results it is concluded that BRL 25000 will be a clinically effective drug in the treatment of mild and moderate infections in the pediatric field."
04/01/1989 - "Augmentin provides safe and effective therapy for infections commonly seen in the pediatric population."
03/01/1986 - "Therefore, BRL 25000 is considered useful for the treatment of genital infections."
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
03/01/1993 - "Amoxycillin/clavulanic acid possesses a high clinical and microbiological efficacy for lower respiratory tract infections."
12/01/1985 - "Amoxycillin/clavulanic acid combination was a safe and effective antimicrobial agent for the treatment of respiratory tract infections."
09/01/2000 - "[Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model]."
05/01/1988 - "This study investigated the effects of clavulanate-potentiated amoxycillin in the management of moderate to severe respiratory tract infections. "
05/01/2015 - "Amoxicillin/clavulanic acid (OR = 4.08, 95% CI 1.57-10.56), and respiratory tract infections (RTI) (OR = 6.17, 95% CI 2.55-14.94) were associated with low compliance with guidelines. "
12/07/1991 - "To determine the efficacy of coamoxiclav in children aged 6 months to 12 years with recurrent acute otitis media. "
12/07/1991 - "Co-amoxiclav in recurrent acute otitis media: placebo controlled study."
01/01/2003 - "Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media."
12/01/2002 - "In the intention to treat analysis the frequency of acute otitis media was 16.2% (16/99) in the placebo group and 9.6% (10/104) in the amoxicillin/clavulanic acid group (P = 0.288). "
12/07/1991 - "Co-amoxiclav has no significant benefit over placebo in treating children over 2 years with acute otitis media."
01/01/2007 - "We investigated the efficacy of 2 formulations of Augmentin on experimental pneumonia due to Haemophilus influenzae (HI) in rabbits. "
01/01/2007 - "Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbits."
01/01/2013 - "Finally, we employ the data taken from a trial comparing once-daily gatifloxican with three-times-daily co-amoxiclav in the treatment of community-acquired pneumonia to illustrate the use of these test procedures and sample size calculation formula. "
11/01/2003 - "This randomized, double-blind, double-dummy, multicentre study compared the efficacy and safety of oral co-amoxiclav 2000/125 mg twice daily versus co-amoxiclav 875/125 mg three times daily, for 7 or 10 days, in the treatment of community-acquired pneumonia (CAP). "
02/01/2011 - "The efficacy and safety of amoxicillin-clavulanic acid 1000/125mg twice daily extended release (XR) tablet for the treatment of bacterial community-acquired pneumonia in adults."
|5.||Urinary Tract Infections (Urinary Tract Infection)
11/01/1985 - "Amoxicillin-clavulanic acid is effective and safe therapy for acute urinary tract infections caused by susceptible bacteria."
09/01/1983 - "Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections."
03/01/1990 - "[Clinical study of Augmentin in urinary tract infections in children]."
01/01/2008 - "difficile diarrhoea after co-amoxiclav therapy for a urinary tract infection. "
02/01/2002 - "Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection."
|2.||Clavulanic Acid (Potassium Clavulanate)
|5.||Anti-Bacterial Agents (Antibiotics)
|1.||Middle Ear Ventilation (Tympanostomy)